• BAPTA Calcium Chelator: Precision for Apoptosis Research

  2026-07-20

  BAPTA enables targeted modulation of intracellular calcium, unlocking mechanistic clarity in apoptosis and cell signaling studies—especially under complex environmental exposures. This article delivers actionable protocols, troubleshooting strategies, and comparative insights, ensuring reproducible results with APExBIO's high-purity standard.

• Tetrahydromagnolol in Metastatic GPCR Research: Beyond CB2 A

  2026-07-19

  Explore how Tetrahydromagnolol, a selective peripheral CB2 receptor agonist, enables advanced modeling of GPCR-driven metastasis. This article uniquely bridges CB2 and orphan GPCR pathways, deepening cannabinoid receptor research for cancer and anti-inflammatory assay design.

• NADPH Oxidase-Derived ROS Regulate Arterial Tone via L-type

  2026-07-18

  This study demonstrates that reactive oxygen species (ROS) produced by NADPH oxidase strongly promote arterial contraction in early postnatal rats by activating L-type voltage-gated Ca2+ channels, independent of Rho-kinase, PKC, or Src-kinase pathways. The findings clarify a specific, developmentally restricted mechanism of vascular regulation, informing future studies of redox-sensitive signaling in the vascular system.

• p21 mRNA-LNPs for Localized Tumor Suppressor Therapy in Blad

  2026-07-17

  This study pioneers the use of intravesical p21 mRNA-loaded lipid nanoparticles (LNPs) as a tumor suppressor replacement strategy in non–muscle-invasive bladder cancer. The approach demonstrates robust local p21 restoration, significant tumor growth suppression, and translational feasibility for targeted mRNA therapy.

• Anlotinib in IADSRCT: Case Evidence and Research Implication

  2026-07-17

  This article examines the first documented use of anlotinib hydrochloride in treating intra-abdominal desmoplastic small round cell tumor (IADSRCT), a rare and aggressive malignancy with limited therapeutic options. The findings highlight anlotinib’s potential as a multi-target tyrosine kinase inhibitor for difficult-to-treat sarcomas, with insights into mechanisms, tolerability, and translational relevance for cancer research.

• Keratinocyte Models and NLRP1 Inflammasome Activation: A Com

  2026-07-16

  This study systematically compares primary and immortalized human keratinocyte cell lines for analyzing NLRP1 inflammasome activation using UVB and talabostat. The authors demonstrate that only primary keratinocytes robustly support NLRP1 inflammasome activation, guiding researchers toward optimal in vitro models for skin immunity research.

• Trelagliptin Succinate Improves Insulin Resistance in Adipoc

  2026-07-16

  This study reveals that trelagliptin succinate, a long-acting DPP-4 inhibitor, enhances insulin signaling in adipocytes by upregulating PI-3K/AKT/GLUT4 pathway components and reducing adverse adipokines. These findings clarify trelagliptin's molecular effects and inform future metabolic disease research.

• HBTU: Precision Peptide Bond Formation for Zwitterionic Ther

  2026-07-15

  Explore how HBTU (2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate) empowers advanced peptide bond formation with outstanding racemization resistance. This article uniquely dissects the mechanistic and strategic considerations for engineering next-generation zwitterionic peptide therapeutics.

• Fungal IAA Controls Ferroptotic Conidial Death in Rice Blast

  2026-07-15

  This study uncovers how indole-3-acetic acid (IAA), produced by Magnaporthe oryzae, regulates ferroptotic cell death in developing conidia by modulating iron and lipid peroxidation. The findings clarify the molecular link between fungal auxin signaling, lipid metabolism, and pathogenicity, providing new avenues for rice blast disease management.

• Cy5 amine (non-sulfonated): Technical Guide for Biomolecule

  2026-07-14

  Cy5 amine (non-sulfonated) addresses the need for a bright, photostable, amine-reactive dye in workflows requiring water-insoluble probes. It is well-suited for protein, peptide, or polymer labeling in fluorescence microscopy and flow cytometry, but is unsuitable for direct aqueous labeling or any clinical diagnostic use.

• Okadaic acid: Technical Guide for Protein Phosphatase 1 Inhi

  2026-07-14

  Okadaic acid is a highly potent inhibitor of serine/threonine protein phosphatases PP1 and PP2A, widely used in apoptosis assays and phosphorylation pathway studies. This guide provides actionable workflow details and handling requirements for reliable results in cell signaling and cancer research. Use is not recommended outside validated biochemical and cellular assay contexts due to its potency and specificity.

• KN-62: Unraveling CaMKII Inhibition in Metabolic and Cancer

  2026-07-13

  Explore how KN-62, 1-[N,O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosy]-4-phenylpiperazine, enables advanced research into CaMKII-driven metabolic and cancer signaling networks. This article uniquely bridges mechanistic insight, metabolic regulation, and autophagy implications in oncology.

• Merimepodib (VX-497): Experimental Workflows & Antiviral Ins

  2026-07-13

  Merimepodib (VX-497) is a selective, noncompetitive IMPDH inhibitor that enables rigorous antiviral, immunosuppressive, and oncology research. This article details protocol design, troubleshooting, and advanced applications, empowering scientists to leverage Merimepodib for host-directed antiviral studies and beyond.

• Cholesterol: Principal Sterol for Advanced Lipid Nanoparticl

  2026-07-12

  Cholesterol’s role as the principal sterol is indispensable in building membrane models and engineering robust lipid nanoparticles, especially for localized mRNA therapies in oncology. This guide delivers evidence-backed protocols, troubleshooting strategies, and direct workflow enhancements for maximizing reproducibility and translational impact using APExBIO’s high-purity cholesterol.

• Selective Nanomolar IRAP Inhibitors via α-Hydroxy-β-Amino Ac

  2026-07-10

  This study introduces a regio- and stereoselective synthetic route to α-hydroxy-β-amino acid derivatives of bestatin, enabling the discovery of potent, nanomolar inhibitors selective for insulin-regulated aminopeptidase (IRAP). The work provides new chemical tools for probing M1 aminopeptidase biology and informs design strategies for selective enzyme inhibition.

508 records 8/34 page Previous Next First page 上5页 678910 下5页 Last page